Citrini tests Anthropic's research model on scorpion antivenom, launches Citrini Therapeutics

Citrini says it spent three months working with Anthropic's internal research model to see whether it could create an experimental scorpion antivenom, and then introduced Citrini Therapeutics in a post on X. The post links to a Citrini Research write-up with more detail, which the reports do not include.

Anthropic separately published research in which its internal model designed protein binders against scorpion neurotoxins over 64 hours. Adaptyv Bio and Twist Bioscience tested 211 designs, and 17 met the binding criteria, all against a single toxin. Anthropic says it has not tested neutralization in cells or animals, does not claim to have produced an antivenom, and is releasing all 211 designs and their binding data.

No independent report yet confirms the results of Citrini's antivenom work.